MediBloc Limited is developing a patient-centered health data ecosystem that protects individual privacy and enhances the reliability of health data through a blockchain-based platform called ‘Panacea’.

MediBloc Limited

Anthem Blue Cross and Blue Shield is dedicated to delivering better care to its members, providing greater value to its customers, and helping improve the health of communities. The company offers affordable health, dental, and vision coverage for individuals and families, Medicare plans, Medicaid plans, and small business plans. It also provides services such as claim submission, benefits review, payment management, prescription management, and live chat support.

Mike Murphy

Anthem Blue Cross and Blue Shield

Deccan Chronicle Holdings Limited is a public limited company engaged in publishing newspapers in India. It owns and publishes English daily newspapers such as Deccan Chronicle, The Asian Age, Financial Chronicle, and Andhra Bhoomi.

Deccan Chronicle Holdings Limited

Embleema offers a data and bioinformatics platform that integrates molecular, clinical, and real-world data to produce insights for personalized medicine. The platform provides tools for participant recruitment, data collection, and regulatory submissions.

Metric
Company Name	MediBloc Limited	Anthem Blue Cross and Blue Shield	Deccan Chronicle Holdings Limited	Embleema
Symbol
MSH ID	COM:MEDIBLOC	COM:ANTHEM	COM:DECCANCHRONICLE	COM:EMBLEEMA
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Consumer Services	Healthcare & Health Services
Industry	Health Technology	Healthcare & Health Services	Media (Newspaper Publishing)	Biotechnology
Country	KR			US
Stage	Venture Round
Employee Count		10.00K	501
Website	medibloc.com	anthem.com	deccanchronicle.com	embleema.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		8.50M
Web Traffic Growth		0.10
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MEDI

COM:MEDIBLOC

MediBloc Limited

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue